Clinical Trial of Ambroxol in Patients With Type I Gaucher Disease

Clinical trial NCT01463215 · SUSPENDED

Trial details

NCT number: NCT01463215
Sponsor: Exsar Corporation
Status: SUSPENDED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Type I Gaucher Disease

Start date: 2012-12-01
Primary completion: 2014-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.